Lamab Biologics
Westmount
About Lamab Biologics
Lamab Biologics operates as a biotechnology company. Lamab Biologics develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $25.0M
- Last round: Series Unknown (Feb 2023)
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/lamab-biologics-79310 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.